Sign In
Buy GLYC
$15.71
+0 (+0%)
At Close: Oct 01, 2025
Barclays PLC Grows Stock Holdings in GlycoMimetics Inc (NASDAQ:GLYC)
09:42am, Wednesday, 18'th Mar 2020
Barclays PLC boosted its holdings in GlycoMimetics Inc (NASDAQ:GLYC) by 42.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutio
GlycoMimetics Inc (NASDAQ:GLYC) Receives $8.75 Average Target Price from Analysts
08:16am, Sunday, 15'th Mar 2020
Shares of GlycoMimetics Inc (NASDAQ:GLYC) have received an average recommendation of “Buy” from the nine analysts that are currently covering the firm, Marketbeat reports. One research analyst has
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
Should You Take Comfort From Insider Transactions At GlycoMimetics, Inc. (NASDAQ:GLYC)?
12:30pm, Wednesday, 11'th Mar 2020
It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be...
Daniel Junius Is The Independent Director of GlycoMimetics, Inc. (NASDAQ:GLYC) And They Just Spent US$68k On Shares
11:36am, Wednesday, 11'th Mar 2020
Even if it's not a huge purchase, we think it was good to see that Daniel Junius, the Independent Director of...
Alambic Investment Management L.P. Decreases Stake in GlycoMimetics Inc (NASDAQ:GLYC)
08:26am, Wednesday, 11'th Mar 2020
Alambic Investment Management L.P. lessened its stake in GlycoMimetics Inc (NASDAQ:GLYC) by 63.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 15,210 shares of
FY2020 Earnings Forecast for GlycoMimetics Inc (NASDAQ:GLYC) Issued By Jefferies Financial Group
08:50am, Friday, 06'th Mar 2020
GlycoMimetics Inc (NASDAQ:GLYC) – Jefferies Financial Group lowered their FY2020 earnings per share (EPS) estimates for GlycoMimetics in a research report issued on Monday, March 2nd. Jefferies Fina
GlycoMimetics Inc Expected to Earn Q1 2020 Earnings of ($0.36) Per Share (NASDAQ:GLYC)
07:46am, Thursday, 05'th Mar 2020
GlycoMimetics Inc (NASDAQ:GLYC) – Investment analysts at Jefferies Financial Group issued their Q1 2020 EPS estimates for GlycoMimetics in a research note issued on Monday, March 2nd. Jefferies Fina
GlycoMimetics Inc (GLYC) Q4 2019 Earnings Call Transcript
10:33pm, Wednesday, 04'th Mar 2020
GLYC earnings call for the period ending December 31, 2019.
California Public Employees Retirement System Acquires 49,800 Shares of GlycoMimetics Inc (NASDAQ:GLYC)
11:42am, Wednesday, 04'th Mar 2020
California Public Employees Retirement System boosted its holdings in shares of GlycoMimetics Inc (NASDAQ:GLYC) by 474.0% in the 4th quarter, according to the company in its most recent 13F filing wit
GlycoMimetics (NASDAQ:GLYC) PT Lowered to $16.00 at HC Wainwright
10:00am, Wednesday, 04'th Mar 2020
GlycoMimetics (NASDAQ:GLYC) had its price objective dropped by investment analysts at HC Wainwright from $18.00 to $16.00 in a research note issued to investors on Monday, BenzingaRatingsTable reports
H.C. Wainwright Reiterates Buy on GlycoMimetics, Lowers Price Target to $16
12:28pm, Monday, 02'nd Mar 2020Analysts Offer Insights on Healthcare Companies: Navidea (NAVB), GlycoMimetics (GLYC) and Akero Therapeutics (AKRO)
12:12pm, Monday, 02'nd Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Navidea (NAVB), GlycoMimetics (GLYC) and Akero Therapeutics
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Navidea (
NAVB
–
Research Report
), GlycoMimetics (
GLYC
–
Research Report
) and Akero Therapeutics
GlycoMimetics: 4Q Earnings Snapshot
01:15pm, Friday, 28'th Feb 2020
ROCKVILLE, Md. (AP) _ GlycoMimetics Inc. (GLYC) on Friday reported a loss of $14.7 million in its fourth quarter.
The Rockville, Maryland-based company said it had a loss of 34 cents per share.
The re
